Regenerative Medicine
of Latin America

Regenerative Medicine of Latin AmericaRegenerative Medicine of Latin AmericaRegenerative Medicine of Latin America
  • Home
  • Innovative Therapies
  • OUR DRUG & ANGIOGENESIS
  • About Us
  • Our Future & Events
  • Contact Us
  • More
    • Home
    • Innovative Therapies
    • OUR DRUG & ANGIOGENESIS
    • About Us
    • Our Future & Events
    • Contact Us

Regenerative Medicine
of Latin America

Regenerative Medicine of Latin AmericaRegenerative Medicine of Latin AmericaRegenerative Medicine of Latin America
  • Home
  • Innovative Therapies
  • OUR DRUG & ANGIOGENESIS
  • About Us
  • Our Future & Events
  • Contact Us

  CLINICAL TRIALS TO START IN 2022 FOR PARKINSON’S AND ALS 

  CLINICAL TRIALS TO START IN 2022 FOR PARKINSON’S AND ALS 

Zambrano Hospital

Zambrano Hospital

Zambrano Hospital

Mexico has given our research partner, Zhittya Genesis Medicine, approval to conduct human clinical trials on patients with Parkinson’s disease and amyotrophic lateral sclerosis (ALS). 

best of the best

Zambrano Hospital

Zambrano Hospital

The trials will be at the world-renowned Zambrano Hospital in Monterey, Mexico. The clinical trials will be supervised by the well-respected clinical research organization (CRO), Cohortias. Zhittya has, or is, filing new applications in Mexico to conduct clinical trials in patients with 1) multiple sclerosis, 2) disabilities from chronic 

The trials will be at the world-renowned Zambrano Hospital in Monterey, Mexico. The clinical trials will be supervised by the well-respected clinical research organization (CRO), Cohortias. Zhittya has, or is, filing new applications in Mexico to conduct clinical trials in patients with 1) multiple sclerosis, 2) disabilities from chronic strokes, 3) Alzheimer’s disease, (4) depression, (5) diabetic foot ulcers, and (6) severe coronary artery disease.

Innovative therapies

Innovative therapies

Innovative therapies

Regenerative Medicine of Latin America (RMLA) owns the rights to drug therapies that are in development to treat Parkinson's Disease, ALS, Stroke Recovery, Alzheimer’s Disease, MSA, Vascular Dementia, CTE, TBI, Diabetic Foot Ulcers, Venous Leg Ulcers, Coronary Artery Disease, Peripheral Artery Disease (PAD), and MS.​ 

Discover more

about us

Innovative therapies

Innovative therapies

 We believe that Regenerative Medicine is the future of healthcare. Many of the problems of our aging bodies are from the lack of blood flow to organs which can cause a number of negative effects on our body and our health.​ 




why we are

leadership

leadership

leadership

 At Regenerative Medicine of Latin America, we have built a great team and have developed relationships that will make us 

successful in reaching our goals.

who we are

our future

leadership

leadership

 Regenerative Medicine of Latin America owns a portfolio of biological drugs that will keep its drug pipeline full for many decades. 


Learn More

Engaged in the Community

to CONTACT Us or for MORE INFORMATIOn

Sign up to receive the latest information, white papers, or to participate in webinars

RMLA: 1120 N. Town Center Drive Suite 270, Las Vegas, NV 89144 USA 
PH: 702.800.0030
Toll Free: 1.844.999.0030 

Copyright © 2021 Sarcastic Lion, LLC - All Rights